The latest lymphoma news, advice, and information, including treatment therapies, diagnosis, expert advice, and real-life stories about people living with Hodgkin’s or non-Hodgkin’s lymphoma.
Lymphoma TopicsShow More
Emily Dumler had 6 months to live after unsuccessful treatment for non-Hodgkin’s lymphoma, but has been in remission for three years since receiving CAR T-cell therapy.
For those diagnosed with cancer, the hardest moments may come after treatment has ended.
Follicular lymphoma is a slow-growing cancer which is not curable but instead is considered a long-term, chronic disease.
Diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma, is aggressive, but up to three-quarters of patients are responsive to treatment.
Having lymphoma or breast cancer was linked to a three-times higher risk of developing heart failure within five years of initial diagnosis.
Hear from a doctor on the front lines of research into CAR T-cell therapy, a promising new immunotherapy for treatment-resistant non-Hodgkin’s lymphoma.
Many survivors find their energy levels sapped after treatment. Find out when your cancer-related fatigue might ease, how to discuss your symptoms with your care team, and steps you can take to accomodate your daily activities.
Non-Hodgkin’s lymphoma symptoms like fatigue, chills, and swollen glands are easy to mistake for minor ailments, but get a checkup if they persist.
What's the key to successful treatment of non-Hodgkin's lymphoma? Understanding your diagnosis and treatment options, according to Dr. Gwen Nichols of the Leukemia & Lymphoma Society. She shares how best to navigate your path forward.
CAR T cell therapy is a new FDA approved immunotherapy for treating non-Hodgkin's lymphoma. Dr. Gwen Nichols explains CAR T's applications, process, and history as a cancer therapy.